Sequential autologous and allogeneic stem cell transplantation for treatment of primary plasma cell leukemia: A case report.

Abstract

Primary plasma cell leukemia (pPCL) is a rare and aggressive form of plasma cell disorder, which accounts for ~70% of all PCL. Survival of pPCL remains poor, and is related with early mortality. There is no standard therapy for patients with pPCL. In the present study, a 26-year-old man who was diagnosed with pPCL was reported. The patient achieved stringent complete remission to the successful treatment of intensive chemotherapy combined with sequential autologous and allogeneic stem cell transplantation (SCT) followed by maintenance therapy with oral administration of ixazomib, thalidomide and dexamethasone (IRD regimen). Development of complex treatment algorithms that combine novel agents, SCT and post-transplantation remission strategies may translate into survival in patients with pPCL.

• Authors: Weijia Fu, Aijie Huang, Yanrong Luo, Miaomiao Liu, Gusheng Tang, Jianmin Yang, Xiong Ni
• Journal: Molecular and clinical oncology (Mol Clin Oncol) Vol. 19 Issue 3 Pg. 75 (Sep 2023) ISSN: 2049-9469 [Electronic] England
• PMID: 37614372 (Publication Type: Case Reports)
• Copyright: Copyright: © Fu et al.